Profiles

Veronika Josefa Wirtz, PhD, MSc

Professor, Global Health - Boston University School of Public Health

vwirtz@bu.edu

Biography

Veronika J. Wirtz, MSc, PhD is a Professor in the Department of Global Health at the Boston University School of Public Health, where she is also Director of the World Health Organization Collaborating Center in Pharmaceutical Policy. Her research focuses on health system strengthening and policy and program evaluations of medicines access and utilization. She is a Visiting Professor of the National Institute of Public Health (INSP) in Mexico.

Her interest and expertise include medicines price analysis, generic medicines policies, quality use of medicines, access to medicines for non-communicable diseases and the role of the private sector to promote equitable access and efficient use of medicines in low and middle income countries. Among other international studies Dr Wirtz carried out cross-national comparison of medicines consumption using large sales data bases to inform policy making about adequate use of medicines and prevention of antimicrobial resistance.

Between 2014 and 2016 she was the Co-Chair of The Lancet Commission on Essential Medicine Policies. The Commission had the goals of (1) re-confirming the ongoing relevance, and the crucial need of comprehensive essential medicines policies to achieve broader global health and sustainable development goals, especially universal health coverage and (2) formulating recommendations for global essential medicine policies for the next two decades. The Report of the Commission Essential Medicines for Universal Coverage was published in 2016.

From 2004 to 2012 she was researcher and lecturer at the National Institute of Public Health (INSP) in Mexico and a founding member and Head of the Medicines in Public Health Research Group which is a multi-disciplinary team of 15 experts in health economics, epidemiology, social science carrying out pharmaceutical policy analysis in Mexico and Latin America. Over the last years she has regularly taught short courses in Pharmacoepidemiology and Medicines Utilization Research at INSP in Mexico.

She has worked as a technical adviser for various international organizations, among them the World Health Organization, the Pan American Health Organization, the World Bank, the Global Fund to fight AIDS, Tuberculosis and Malaria, the Bill and Melinda Gates Foundation, Alliance for Health Systems and Policy Research, Health Action International and the Ford Foundation. She has also worked with the Ministry of Health in Mexico on various program evaluations and capacity building initiatives. She published widely in international peer review journals such as The Lancet, British Medical Journal, World Health Organization Bulletin, Health Policy and Planning, Health Policy, Value in Health, Social Science and Medicine, Tropical Medicine and International Health. Since Fall 2016 she is Associate Editor of Health Systems & Reform, a leading journal publishing health system and policy research.

She received her training as a pharmacist from Albert-Ludwigs-University in Freiburg, Germany and her Master in Clinical Pharmacy and PhD from the University of London in the UK.

Education

  • University of London, PhD Field of Study: Pharmaceutical Policy
  • University of London, MSc Field of Study: Pharmacy
  • Albert-Ludwigs-Universität Freiburg, BS Field of Study: Pharmacy

Classes Taught

  • SPHGH722
  • SPHGH760
  • SPHGH888
  • SPHGH941

Publications

  • Published on 12/9/2025

    Veronika J. Wirtz, Klara Tisocki. Arzneimittel-Kompass 2025. Die Preisfrage: Wege zu fairen Loesungen. Faire Preise im Fokus – Strategien fuer eine gerechte Arzneimittelpreispolitik. Chapter 10. Springer. Berlin. 2025; 1(1):133-152.

    Read At: Custom
  • Published on 11/13/2025

    Brook Baker, Deborah Gleeson, Brigitte Tenni, Rachel Thrasher, Veronika J. Wirtz. . Report on compulsory licensing provisions in the national patent legislation of 15 middle-income countries: a content analysis and recommendations. South Center/Global Development Policy Center. Geneva/Boston. 2025; 108.

  • Published on 11/11/2025

    Gozzer E, Becerra-Chauca N, Abba-Aji M, Wirtz VJ, Cordoba G, Canchihuamán F, Nagassar RP, Yañez-Diaz S, Brou PS, Delgado-Flores CJ, Fazaludeen Koya S. Antimicrobial resistance interventions in Latin America and the Caribbean: a scoping review of reported interventions between 2018-2024. Antimicrob Resist Infect Control. 2025 Nov 11; 14(1):137. PMID: 41220030.

    Read At: PubMed
  • Published on 10/14/2025

    Ching C, Zaman MH, Wirtz VJ. Limited integration of one health and antimicrobial resistance within biodiversity strategies. Discov Public Health. 2025; 22(1):612. PMID: 41104312.

    Read At: PubMed
  • Published on 7/10/2025

    Ching C, Zaman MH, Wirtz VJ. Policy discourse on AMR in food-producing animals: examining framing and language for effective communication. JAC Antimicrob Resist. 2025 Aug; 7(4):dlaf113. PMID: 40642516.

    Read At: PubMed
  • Published on 5/21/2025

    Wirtz VJ, Hogerzeil HV, Gray AL. Accelerating progress on essential medicines: a new Lancet Commission. Lancet. 2025 Oct 25; 406(10514):1932-1933. PMID: 40412429.

    Read At: PubMed
  • Published on 4/27/2025

    Pilar Torres-Pereda, Anahi Dreser-Mansilla, Andrea Anaya-Sanchez, Ricardo Escalera-Ulloa, Tonatiuh Gonzalez-Vazquez, Jennifer Hegewisch-Taylor, Gabriel Millan-Garduño, F Ortega, Veronika J. Wirtz . Desentrañando la infodemia: El rol de WhatsApp en la desinformación sobre COVID-19 en México. Salud UIS. 2025; 57:e25v57a06.

    Read At: Custom
  • Published on 4/3/2025

    Caetano MC, Emmerick ICM, Campos MR, Pires DC, Wirtz VJ, Luiza VL. Effect of Covid-19 pandemic on azithromycin, chloroquine/hydroxychloroquine and ivermectin outpatient consumption in Brazil: a joinpoint regression analysis. BMC Public Health. 2025 Apr 03; 25(1):1250. PMID: 40181299.

    Read At: PubMed
  • Published on 3/29/2025

    Goto A, Wirtz VJ, Hayashi M, Hasegawa J, Fukushima K, Matsuda H, Nakai A. Access to medical abortion and abortion care in Japan. Prev Med Rep. 2025 May; 53:103041. PMID: 40264747.

    Read At: PubMed
  • Published on 3/17/2025

    Costa E, Del Grosso V, Cappello B, Genazzani AA, Huttner B, Leufkens HGM, Magrini N, Nonino F, Wirtz VJ, van den Ham HA, Moja L. Medicines not recommended for inclusion in the who essential medicines list: a retrospective observational study. Front Med (Lausanne). 2025; 12:1517020. PMID: 40166059.

    Read At: PubMed

News & In the Media